Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     

LEMAITRE VASCULAR, INC.

(LMAT)
  Report
Delayed Nasdaq  -  04:00:00 2023-02-03 pm EST
50.05 USD   +0.50%
2022LeMaitre to Present at Upcoming Investor Conferences
AQ
2022LEMAITRE VASCULAR, INC. : Ex-dividend day for
FA
2022LEMAITRE VASCULAR INC Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)
AQ
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisionsFunds 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

LeMaitre: Q3 Earnings Snapshot

10/27/2022 | 05:30pm EST

BURLINGTON, Mass. (AP) _ LeMaitre Vascular Inc. (LMAT) on Thursday reported third-quarter earnings of $5.5 million.

On a per-share basis, the Burlington, Massachusetts-based company said it had profit of 25 cents.

The results fell short of Wall Street expectations. The average estimate of four analysts surveyed by Zacks Investment Research was for earnings of 28 cents per share.

The medical device maker posted revenue of $39 million in the period, also falling short of Street forecasts. Five analysts surveyed by Zacks expected $40.1 million.

For the current quarter ending in December, LeMaitre said it expects revenue in the range of $39.8 million to $42.2 million.

The company expects full-year earnings in the range of $1.02 to $1.08 per share, with revenue ranging from $160.5 million to $162.9 million.

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on LMAT at https://www.zacks.com/ap/LMAT

Copyright by Automated Insights, Inc. All rights reserved., source Associated Press News

All news about LEMAITRE VASCULAR, INC.
2022LeMaitre to Present at Upcoming Investor Conferences
AQ
2022LEMAITRE VASCULAR, INC. : Ex-dividend day for
FA
2022LEMAITRE VASCULAR INC Management's Discussion and Analysis of Financial Condition and ..
AQ
2022Tranche Update on LeMaitre Vascular, Inc.'s Equity Buyback Plan announced on February 2..
CI
2022LeMaitre to Present at Upcoming Investor Conferences
AQ
2022North American Morning Briefing: Futures Pull -3-
DJ
2022Barrington Research Downgrades LeMaitre Vascular to Market Perform From Outperform
MT
2022Lemaitre : Q3 Earnings Snapshot
AQ
2022Transcript : LeMaitre Vascular, Inc., Q3 2022 Earnings Call, Oct 27, 2022
CI
2022LeMaitre Vascular, Inc. Reports Earnings Results for the Third Quarter and Nine Months ..
CI
More news
Analyst Recommendations on LEMAITRE VASCULAR, INC.
More recommendations
Financials (USD)
Sales 2022 162 M - -
Net income 2022 20,7 M - -
Net Debt 2022 - - -
P/E ratio 2022 53,8x
Yield 2022 1,00%
Capitalization 1 101 M 1 101 M -
Capi. / Sales 2022 6,81x
Capi. / Sales 2023 6,43x
Nbr of Employees 469
Free-Float 82,5%
Chart LEMAITRE VASCULAR, INC.
Duration : Period :
LeMaitre Vascular, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends LEMAITRE VASCULAR, INC.
Short TermMid-TermLong Term
TrendsBullishNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 7
Last Close Price 50,05 $
Average target price 56,60 $
Spread / Average Target 13,1%
EPS Revisions
Managers and Directors
George W. LeMaitre Chairman & Chief Executive Officer
David B. Roberts Chief Financial Officer
Joseph P. Pellegrino Chief Financial Officer, Secretary & Director
Jonathan W. Ngau Director-Information Technology
Ryan H. Connelly Vice President-Research & Development
Sector and Competitors
1st jan.Capi. (M$)
LEMAITRE VASCULAR, INC.8.76%1 101
THERMO FISHER SCIENTIFIC6.73%231 606
DANAHER CORPORATION1.98%196 532
INTUITIVE SURGICAL, INC.-4.02%90 000
BOSTON SCIENTIFIC CORPORATION3.89%69 467
SIEMENS HEALTHINEERS AG15.64%65 645